Non Insulin Dependent Diabetes Clinical Trial
Official title:
Curcumin Supplementation and Type 2 Diabetes
Diabetes mellitus is the most common endocrine disorder, causes many complications such as micro- and macro-vascular diseases. Various kinds of antidiabetic drugs have been developed, but most of them have side effects. Recently, the use of natural plant products has gained more attention among scientists in order to prevent diabetic vascular complications. Curcumin is a natural yellow product derived from the turmeric rhizome which has shown to be non-toxic and exhibits various bio¬logical activities such as anti-oxidant, anti-inflammatory, anti-carcinogenic, and anti-diabetic effects. Curcumin is effective in reducing glycemic index and hyperlipidemia in rodent models and is relatively inexpensive and safe. Most of the studies conducted on animal model, and just a few of them are on human model. The present study was planned to evaluate the effects of curcumin supplementation on serum levels of lipid profile and inflammatory markers in patients with type 2 diabetes
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03073343 -
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
|
N/A | |
| Completed |
NCT02529982 -
Curcumin Supplementation and Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT01745900 -
Evaluation and Comparison of Noninvasive Blood Glucose Concentrations
|
N/A | |
| Completed |
NCT00835861 -
Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes
|
Phase 2 |